The Microbiome and Pediatric Transplantation

Caitlin W Elgarten,Elisa B Margolis,Matthew S Kelly

DOI: https://doi.org/10.1093/jpids/piad062

2024-02-29

Journal of the Pediatric Infectious Diseases Society

Abstract:The microbial communities that inhabit our bodies have been increasingly linked to host physiology and pathophysiology. This microbiome, through its role in colonization resistance, influences the risk of infections after transplantation, including those caused by multidrug-resistant organisms. In addition, through both direct interactions with the host immune system and via the production of metabolites that impact local and systemic immunity, the microbiome plays an important role in the establishment of immune tolerance after transplantation, and conversely, in the development of graft-versus-host disease and graft rejection. This review offers a comprehensive overview of the evidence for the role of the microbiome in hematopoietic cell and solid organ transplant complications, drivers of microbiome shift during transplantation, and the potential of microbiome-based therapies to improve pediatric transplantation outcomes.

pediatrics,infectious diseases

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: **To explore the role of the microbiota in pediatric transplantation (including hematopoietic cell transplantation and solid - organ transplantation) and its impact on transplantation outcomes, especially how to improve the post - transplantation infection risk, graft - versus - host disease (GVHD), graft rejection, and immune recovery through changes in the microbiota.**

Specifically, the article mainly focuses on the following aspects:

1. **The relationship between the microbiota and transplantation complications**:
- The article reviews existing evidence, indicating that the microbiota affects post - transplantation complications, such as infections caused by multi - drug - resistant bacteria, GVHD, and graft rejection, through its roles in colonization resistance and the establishment of immune tolerance.

2. **Drivers of microbiota changes during the transplantation process**:
- It discusses the effects of antibiotic use, dietary changes, gut epithelial damage caused by chemotherapy, and immunosuppressive drugs on the microbiota. These factors can lead to the loss of beneficial bacteria and an increase in potential pathogenic bacteria, thus affecting transplantation outcomes.

3. **The therapeutic potential based on the microbiota**:
- It explores the possibility of improving transplantation outcomes by modulating the microbiota, including the application prospects of dietary adjustment, selective antibiotic use, and emerging therapies such as fecal microbiota transplantation (FMT).

### Summary of key issues

- **Infection risk**: A decrease in microbiota diversity and changes in specific microbiota are associated with an increased risk of post - transplantation infection.
- **Graft - versus - host disease (GVHD)**: A low - diversity microbiota and a reduction in specific microbiota are associated with an increased risk of acute GVHD.
- **Immune recovery**: The microbiota may affect the reconstitution of immune cells, thereby affecting post - transplantation immune recovery.
- **Antibiotic resistance**: Antibiotic exposure is associated with an increased risk of colonization and infection by multi - drug - resistant organisms (MDROs).

### Formula representation

Although this article does not involve complex mathematical or physical formulas, the Shannon diversity index can be used to measure microbiota diversity:

\[ H = -\sum_{i = 1}^{S} p_i\log(p_i) \]

where \( H \) is the Shannon diversity index, \( S \) is the number of species, and \( p_i \) is the proportion of the \( i \) - th species.

Through these studies, the authors hope to provide new perspectives and potential intervention strategies for pediatric transplantation to improve patient prognosis.